Active Ingredient
Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)
The following Structured Product Label (SPL) was submitted to the FDA by Rugby Laboratories for the product Olopatadine Hydrochloride (NDC 0536-1307). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, do not use, when using this product, stop use and ask doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)
Antihistamine
temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander
For external use only
you experience:
If swallowed, get medical help or contact a Poison Control Center right away.
• only for use in the eye
• store between 2° to 25°C (36° to 77°F)
Benzalkonium chloride 0.01%, Dibasic sodium phosphate, Edetate disodium, Hydrochloric acid/Sodium hydroxide (adjust pH), Povidone, Sodium chloride, and Water for Injection.
Call 1-888-375-3784
Distributed by:
RUGBY® LABORATORIES
Indianapolis, IN 46268
(800) 616-2471
www.major-rugby.com
Made in India
Rev. 04/25
R-145 Re-order No. 371043
*This product is not manufactured or distributed by Alcon Laboratories Inc., distributor of Pataday® Once Daily Relief . Pataday® is a registered trademark of Novartis AG.
NDC 0536-1307-23
Olopatadine HCl
Ophthalmic Solution
USP, 0.2%
antihistamine
once daily
eye allergy itch relief
original prescription strength
works in minutes
relief from allergens:
• pet dander
• pollen
• grass
• ragweed
2.5 mL (0.085 FL OZ)
sterile
Compare to active ingredient in Pataday Once Daily Relief*
Packaged with Tamper-Evident bottle cap. Do Not Use if breakable ring is separated or missing.
For Ages 2 and Older
30 DAY SUPPLY
* Please review the disclaimer below.